Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study

Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study

In response to the raging COVID-19 pandemic, Bangladesh started its vaccine administration in early 2021; however, due to the rapid development and launch of the vaccines in the market, many people had concerns regarding the safety of these vaccines. The purpose of this study was to evaluate the sid...

Full description

Bibliographic Details
Main Authors: Nishat Jahan, Fahad Imtiaz Rahman, Poushali Saha, Sadia Afruz Ether, ASM Roknuzzaman, Rapty Sarker, Khondoker Tashya Kalam, Kashfa Haq, Julkar Nyeen, Humayra Zaman Himi, Md. Nazmul Hossain, Mahtab Hossain Chowdhury, Mostafa Moin Uddin, Nur Haque Alam
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Infectious Disease Reports
Subjects:
COVID-19
Covishield
Oxford-AstraZeneca
post-vaccination side effects
Online Access:https://www.mdpi.com/2036-7449/13/4/80

Similar Items

Similar Items